Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revlon Climbing Back From Vital Radiance With New Releases For 2008

This article was originally published in The Rose Sheet

Executive Summary

Revlon will hop onto the mineral makeup trend as well as offer innovative packaging and limited edition items in order to maintain momentum in 2008

You may also be interested in...



Women’s Hair Color, Almay Boost Revlon U.S. Sales In ’07

Revlon's increased shipments of beauty products, primarily women's hair color and Almay color cosmetics, drove a 5.1 percent increase in the firm's U.S. revenue in 2007 to $804.2 million, the company reported Feb. 28

Women’s Hair Color, Almay Boost Revlon U.S. Sales In ’07

Revlon's increased shipments of beauty products, primarily women's hair color and Almay color cosmetics, drove a 5.1 percent increase in the firm's U.S. revenue in 2007 to $804.2 million, the company reported Feb. 28

Sales & Earnings In Brief

Procter & Gamble: Double-digit growth of P&G's prestige fragrances business was central to fourth-quarter and fiscal 2007 growth, according to an Aug. 3 release. Full-year net beauty sales increased 9% to $23.0 billion, firm says, attributing growth to Boss Selection and Boss Femme fragrance initiatives and the addition of Dolce & Gabbana's The One through a July 2006 licensing deal (1"The Rose Sheet" Dec. 19, 2005, In Brief). High single-digit skin-care growth was driven by Olay Definity and Regenerist, while hair-care sales increased by mid-single-digits on strong performances from Pantene, Head & Shoulders and Herbal Essences, P&G says. Q4 beauty sales totaled $5.9 bil., up 8%, with significant contributions coming from Escada and Lacoste within firm's prestige fragrances segment, as well as Dolce & Gabbana. Overall, company sales for the year rose 12% to $76.5 bil. Fourth-quarter revenue was up 8% to $19.3 bil. Double-digit increases in Blades & Razors and Health Care divisions were driven by sales of Gillette Fusion and Crest Pro-Health; Fiscal 2008 sales are expected to grow 5% to 7%...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015088

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel